Welcome to our dedicated page for Lifeway Foods SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lifeway Foods's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lifeway Foods's regulatory disclosures and financial reporting.
Lifeway Foods director Jason Scher has filed Form 144, indicating his intention to sell 8,200 shares of common stock with an aggregate market value of $198,604 through Morgan Stanley Smith Barney LLC. The planned sale is scheduled for June 26, 2025, on the NASDAQ exchange.
The shares to be sold were acquired through multiple compensation-based private acquisitions from the issuer between 2019-2021, including:
- 1,648 shares on June 15, 2019
- 1,647 shares on June 15, 2020
- 2,740 shares on June 20, 2020
- 1,647 shares on June 15, 2021
- 518 shares on June 20, 2021
The filing indicates that Scher has not sold any company securities in the past three months and affirms no knowledge of undisclosed material adverse information regarding Lifeway Foods' operations. The company currently has 15,203,241 shares outstanding.
Lifeway Foods announced a Separation Agreement with former executive Amy Feldman on June 16, 2025. The agreement includes significant compensation and equity arrangements:
- A lump sum payment of $555,313.13, subject to statutory deductions
- Immediate vesting of 7,875 restricted stock units
- Vesting of 5,448 performance stock units under the 2022 Omnibus Incentive Plan
The agreement includes a comprehensive release of claims by Feldman and confirms that no additional compensation or benefits will be provided beyond those specified. The settlement fulfills all obligations under Feldman's original executive employment agreement from October 31, 2018. This material event follows her previously reported termination announced in March 2025.